Gene · 54888
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to "[NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB-STAT3 signalling in a non-m5C manner]". | Clin Transl Med | 2026 | 42387935 | PubTator, text mining | PubMed |
| How NSUN2 reshapes tRNA for m5C modification. | Sci China Life Sci | 2026 | 42377892 | PubTator, text mining | PubMed |
| NSUN2 mediates SALL2 m5C methylation to inhibit ferroptosis and promote breast cancer progression. | Cancer Biol Ther | 2026 | 42377119 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C modification of BHLF1 RNA facilitates the lytic replication of Epstein-Barr virus. | Cell Rep | 2026 | 42313563 | PubTator, text mining | PubMed |
| ETV4 Improves Cerebral Ischemia-Reperfusion Injury by Restraining YBX1-GPX4-Ferroptosis Cascades. | Brain Behav | 2026 | 42304629 | PubTator, text mining | PubMed |
| Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasion. | Neoplasia | 2026 | 42284680 | PubTator, text mining | PubMed |
| Structure-driven RNA remodeling underlies broad substrate recognition by NSUN2. | Sci China Life Sci | 2026 | 42258135 | PubTator, text mining | PubMed |
Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer. | Respir Res | 2026 | 42231351 | PubTator, text mining | PubMed |
| Substrate selectivity of the human RNA m5C methyltransferase NSUN2. | Nature | 2026 | 42203868 | PubTator, text mining | PubMed |
| The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma. | Mol Cell Probes | 2026 | 42177998 | PubTator, text mining | PubMed |
| Linc00347 suppresses ferroptosis in drug-resistant gastric cancer cells through stabilizing FoxO6 mRNA mediated by YBX1. | Int J Biol Macromol | 2026 | 42155744 | PubTator, text mining | PubMed |
| Global research trends on the relationship between RNA m5C modification and cancer progression: a comprehensive visualization and bibliometric analysis (1900-2024). | Biophys Rep | 2026 | 42109825 | PubTator, text mining | PubMed |
| NSUN2/ALYREF stabilizes m5C-modified circCEP70 to enhance radioresistance in rectal cancer through NEDD8-dependent neddylation and ubiquitination regulation. | Int J Biol Macromol | 2026 | 42106046 | PubTator, text mining | PubMed |
| A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma. | Int J Biol Sci | 2026 | 42088430 | PubTator, text mining | PubMed |
| RNA methylation in cardiovascular remodeling: Molecular mechanisms, biomarkers, and therapeutic strategies. | Mol Biol Rep | 2026 | 42084676 | PubTator, text mining | PubMed |
| NSUN2 restrains renal fibrosis via m5C-stabilized GPX4 and ferroptosis inhibition. | Cell Signal | 2026 | 42025889 | PubTator, text mining | PubMed |
| Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer. | Biochem Pharmacol | 2026 | 42002235 | PubTator, text mining | PubMed |
| NSUN2-mediated GATM m5C methylation regulates creatine metabolism to drive mitochondrial fission and promote renal fibrosis. | Cell Rep | 2026 | 41999600 | PubTator, text mining | PubMed |
| NSUN2-mediated RNA m5C dysregulation links HBV infection to TFEB silencing and lysosomal impairment. | Antiviral Res | 2026 | 41974311 | PubTator, text mining | PubMed |
| NSUN2/ALYREF-mediated RNA m5c modification promotes anoikis resistance of prostate cancer through activating autophagy. | Oncogene | 2026 | 41946994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54888/papers?page=2